MedTrace Logo

Bitter Taste Receptors in Oropharynx Cancer

NCT05211427 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-03-15

No results posted yet for this study

Summary

The aim of this work is to investigate the expression of the bitter taste receptors in p16-positive and negative oropharyngeal carcinomas (in comparison to healthy, local tissue).

Conditions

  • Oropharynx Cancer

Interventions

PROCEDURE

Biopsy

Biopsy of an oropharynx tumor or of a healthy oropharynx mucosa

Sponsors & Collaborators

  • Thomas Hummel

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-23
Primary Completion
2025-02-28
Completion
2025-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05211427 on ClinicalTrials.gov